PT3554474T - Composições de micafungina - Google Patents

Composições de micafungina

Info

Publication number
PT3554474T
PT3554474T PT178294120T PT17829412T PT3554474T PT 3554474 T PT3554474 T PT 3554474T PT 178294120 T PT178294120 T PT 178294120T PT 17829412 T PT17829412 T PT 17829412T PT 3554474 T PT3554474 T PT 3554474T
Authority
PT
Portugal
Prior art keywords
micafungin
compositions
micafungin compositions
Prior art date
Application number
PT178294120T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Baxter Healthcare Sa
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare Sa, Baxter Int filed Critical Baxter Healthcare Sa
Publication of PT3554474T publication Critical patent/PT3554474T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT178294120T 2016-12-16 2017-12-15 Composições de micafungina PT3554474T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662435695P 2016-12-16 2016-12-16

Publications (1)

Publication Number Publication Date
PT3554474T true PT3554474T (pt) 2024-02-12

Family

ID=60972375

Family Applications (1)

Application Number Title Priority Date Filing Date
PT178294120T PT3554474T (pt) 2016-12-16 2017-12-15 Composições de micafungina

Country Status (11)

Country Link
US (2) US12403173B2 (https=)
EP (1) EP3554474B1 (https=)
JP (2) JP2020510619A (https=)
AU (1) AU2017376960B2 (https=)
DK (1) DK3554474T3 (https=)
ES (1) ES2972008T3 (https=)
FI (1) FI3554474T3 (https=)
HU (1) HUE066069T2 (https=)
PL (1) PL3554474T3 (https=)
PT (1) PT3554474T (https=)
WO (1) WO2018112330A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111044636A (zh) * 2019-12-30 2020-04-21 卓和药业集团有限公司 米卡芬净含量的分析方法
US20220040092A1 (en) * 2020-06-27 2022-02-10 RK Pharma Solutions LLC Ready to use injectable formulations of Micafungin Sodium
CN112710753A (zh) * 2020-12-18 2021-04-27 卓和药业集团有限公司 米卡芬净有关物质的分析方法
WO2024233925A1 (en) * 2023-05-11 2024-11-14 Hikma Pharmaceuticals Usa Inc. Stable micafungin compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849843A (en) 1993-11-16 1998-12-15 Baxter International Inc. Polymeric compositions for medical packaging and devices
US5998019A (en) 1993-11-16 1999-12-07 Baxter International Inc. Multi-layered polymer structure for medical products
RU2165423C2 (ru) 1994-10-07 2001-04-20 Фудзисава Фармасьютикал Ко., Лтд. Полипептидное соединение, способ его получения и фармацевтическая композиция
TWI233805B (en) 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
EP1193261A1 (en) 2000-10-02 2002-04-03 Warner-Lambert Company New thiadiazoles and their use as phosphodiesterase-7 inhibitors
US6991800B2 (en) * 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
PL1778720T3 (pl) 2004-08-18 2011-03-31 Novabiotics Ltd Antybakteryjne peptydy zawierające wzór zawierający argininę i/lub lizynę
EP2146702A2 (en) 2007-05-03 2010-01-27 NorthEastern University Methods of treating fungal infections
AU2013254940A1 (en) 2008-04-21 2014-01-16 Otonomy, Inc. Auris formulations for treating otic diseases and conditions
US8183233B2 (en) 2008-05-15 2012-05-22 Baxter International Inc. Stable pharmaceutical formulations
GB0817121D0 (en) 2008-09-18 2008-10-29 Univ St Andrews Anti-fungal therapy
WO2010110686A1 (en) 2009-03-27 2010-09-30 Pathway Therapeutics Limited Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
US20110071072A1 (en) * 2009-08-28 2011-03-24 Georgetown University, A Congressionally Chartered Institution Of Higher Education Antifungal Bone Cements
CN102614492B (zh) * 2011-01-31 2013-12-11 上海天伟生物制药有限公司 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物
CN102775476B (zh) * 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
CN102512379B (zh) * 2011-12-16 2017-03-08 深圳市健元医药科技有限公司 一种新型棘白菌素类抗真菌药物组合物及其制备方法
SI3677252T1 (sl) 2012-03-19 2024-02-29 Cidara Therapeutics, Inc. Sheme odmerjanja za spojine iz razreda ehinokandinov
ES2777942T3 (es) * 2014-12-31 2022-04-22 Galenicum Health S L U Composiciones farmacéuticas estables que comprenden micafungina
SG11201802832UA (en) * 2015-10-07 2018-05-30 Sumitomo Dainippon Pharma Co Ltd Pyrimidine compound
IN2015MU03858A (https=) * 2015-10-10 2015-10-23 Gufic Biosciences Ltd

Also Published As

Publication number Publication date
ES2972008T3 (es) 2024-06-10
FI3554474T3 (fi) 2024-02-21
EP3554474B1 (en) 2023-12-06
JP2024012211A (ja) 2024-01-25
US12403173B2 (en) 2025-09-02
US20180169180A1 (en) 2018-06-21
JP2020510619A (ja) 2020-04-09
AU2017376960A1 (en) 2019-05-23
US20250345386A1 (en) 2025-11-13
PL3554474T3 (pl) 2024-04-15
HUE066069T2 (hu) 2024-07-28
WO2018112330A1 (en) 2018-06-21
EP3554474A1 (en) 2019-10-23
AU2017376960B2 (en) 2023-12-14
DK3554474T3 (da) 2024-02-19

Similar Documents

Publication Publication Date Title
HRP20210342T8 (hr) Pripravci glikopeptida
IL261792B (en) Preparations
IL260933A (en) Preparations containing tocorsol or its analogues
GB201610156D0 (en) Cliptac compositions
SG11201705415YA (en) Multi-supplement compositions
IL257131A (en) Preparations
GB201515387D0 (en) Compositions
GB201501598D0 (en) Compositions
IL256559A (en) Flinbolin preparations
GB201515391D0 (en) Compositions
IL251954A0 (en) Preparations containing cyclosporine
SI3349766T1 (sl) Antihemoragični sestavki
PL3058958T3 (pl) Kompozycja anidulafunginy
PT3554474T (pt) Composições de micafungina
GB201622161D0 (en) Compositions
GB201614799D0 (en) Compositions
GB201610628D0 (en) New compositions
GB2538335B (en) Compositions
GB201602658D0 (en) Compositions
GB201602579D0 (en) New compositions
HUE050837T2 (hu) Készítmények
GB201614230D0 (en) Compositions
GB201611960D0 (en) Compositions
GB201611851D0 (en) Compositions
GB201602656D0 (en) Compositions